A Randomized, Double-blind, Parallel, Placebo-controlled Study for the Assessment of the Safety and Efficacy of BTL-TML-HSV for the Treatment of Recurrent Symptomatic Oral Herpes Virus Infection
Phase of Trial: Phase I/II
Latest Information Update: 21 Jul 2015
At a glance
- Drugs BTL-TML001 (Primary)
- Indications Herpetic stomatitis
- Focus Therapeutic Use
- Sponsors Beech Tree Labs
- 21 Jul 2015 Pooled analysis results of this and another phase II trial (CTP 235128) were published in a Beech Tree Labs media release.
- 02 Oct 2012 Planned End Date changed from 1 Jun 2012 to 1 Nov 2012 as reported by ClinicalTrials.gov.
- 04 Jan 2012 Planned end date changed from 1 Feb 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.